| Literature DB >> 28791729 |
Abstract
Epilepsy is the quintessential circuit disorder, with seizure activity propagating through anatomically constrained pathways. These pathways, necessary for normal sensory, motor, and cognitive function, are hijacked during seizures. Understanding the network architecture at the level of both local microcircuits and distributed macrocircuits may provide new therapeutic avenues for the treatment of epilepsy. Over the past decade, optogenetic and chemogenetic tools have enabled previously impossible levels of functional circuit mapping in neuroscience. In this review, examples of the application of optogenetics and chemogenetics to epilepsy are raised, the comparative strengths and weaknesses of these approaches are discussed for both preclinical and translational applications, and recent applications of these approaches in other areas of neuroscience are highlighted. These points are raised in an effort to highlight the potential of these methods to address additional unanswered questions in epilepsy.Entities:
Keywords: CNO; Channelrhodopsin; DREADD; Daun02
Mesh:
Year: 2017 PMID: 28791729 PMCID: PMC5647238 DOI: 10.1002/jnr.24135
Source DB: PubMed Journal: J Neurosci Res ISSN: 0360-4012 Impact factor: 4.164